发明名称 Therapeutical method for the treatment of the Leber optic neuropathy
摘要 It is described the use of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, for the preparation of a medicament or a nutritional supplement useful for preventing or treating the Leber optic neuropathy.
申请公布号 US9114120(B2) 申请公布日期 2015.08.25
申请号 US201113988557 申请日期 2011.09.09
申请人 SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE, S.P.A. 发明人 Cavazza Claudio;Koverech Aleardo;D'Iddio Stefania
分类号 A61K31/221;A23L1/305;A61K31/205;A61K45/06 主分类号 A61K31/221
代理机构 Lucas & Mercanti, LLP 代理人 Lucas & Mercanti, LLP
主权项 1. Method for treating the Leber optic neuropathy, said method comprising orally administering to a patient suffering from Leber optic neuropathy an amount of L-carnitine and/or one or more alkanoyl L-carnitines, or mixture thereof, or one of their pharmaceutically acceptable salts, administered orally in a dose of 0.5-4 g/day, in a single or divided dose for 12 months, to treat the Leber optic neuropathy in said patient.
地址 Rome IT